Analyst Ratings for Arrowhead Pharma (ARWR)
ARWR Rating Summary
ARWR Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$85.90 (+15.3%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
Avg. $ Target:
$85.90 (+15.3%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/1/2026 | JPMorgan | Brian Cheng | New Coverage | Overweight (N/A) |
88.00 (N/A) |
70.53 (74.52) |
5.66% | Details |
| 4/21/2026 | Morgan Stanley | Michael E. Ulz | Upgrade | Overweight (Equalweight) |
100.00 (78.00) |
69.51 (74.52) |
7.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
